Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial
Titel:
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial
Auteur:
Kievit, H. Muntinghe-Wagenaar, M.B. Hijmering-Kappelle, L.B.M. Hiddinga, B.I. Ubbels, J.F. Wijsman, R. Slingers, G. de Vries, R. Groen, H.J.M Kerstjens, H.A.M. van der Wekken, A.J. Hiltermann, T.J.N.